Biotech startup Structure pulls off rare IPO, raising $161M
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Third Harmonic Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Biden administration revives free at-home COVID-19 tests; CDC releases new BMI charts for children with severe obesity.
Prime Medicine has yet to test prime editing in humans, but the biotech company garnered enough investor interest to boost the size of its IPO, raising $175 million. Prime claims its technology has key advantages over other gene-editing technologies and the IPO cash will support a pipeline that currently spans 18 programs.